SFG Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,407
Closed -$253K 121
2025
Q4
$253K Buy
+2,407
New +$226K 0.1% 116
2024
Q1
Sell
-1,970
Closed -$215K 101
2023
Q4
$215K Sell
1,970
-4
-0.2% -$415 0.14% 89
2023
Q3
$203K Buy
1,974
+66
+3% +$7.11K 0.16% 91
2023
Q2
$220K Buy
+1,908
New +$217K 0.18% 86
2023
Q1
Sell
-2,296
Closed -$255K 85
2022
Q4
$255K Buy
+2,296
New +$235K 0.31% 61
2022
Q3
Sell
-2,344
Closed -$214K 88
2022
Q2
$214K Buy
+2,344
New +$208K 0.25% 73

Other funds holding MRK

SFG Wealth Management's MRK Position: Q1 2026 in Review

SFG Wealth Management sold out of Merck (MRK) in Q1 2026, closing a stake of 2,407 shares — an estimated $253K sold.

SFG Wealth Management first reported a position in MRK in Q2 2022 and held it in 6 quarters. The position peaked at $255K in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SFG Wealth Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • SFG Wealth Management sold 2,407 Merck shares in Q1 2026, an estimated $253K.
  • SFG Wealth Management first reported a position in Merck in Q2 2022 and held it in 6 quarters.
  • SFG Wealth Management's Merck position peaked at $255K in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SFG Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.